TY - JOUR
T1 - Derivation and validation of the Denver Human Immunodeficiency Virus (HIV) risk score for targeted HIV screening
AU - Haukoos, Jason S.
AU - Lyons, Michael S.
AU - Lindsell, Christopher J.
AU - Hopkins, Emily
AU - Bender, Brooke
AU - Rothman, Richard E.
AU - Hsieh, Yu Hsiang
AU - MacLaren, Lynsay A.
AU - Thrun, Mark W.
AU - Sasson, Comilla
AU - Byyny, Richard L.
PY - 2012/4/15
Y1 - 2012/4/15
N2 - Targeted screening remains an important approach to human immunodeficiency virus (HIV) testing. The authors aimed to derive and validate an instrument to accurately identify patients at risk for HIV infection, using patient data from a metropolitan sexually transmitted disease clinic in Denver, Colorado (1996-2008). With multivariable logistic regression, they developed a risk score from 48 candidate variables using newly identified HIV infection as the outcome. Validation was performed using an independent population from an urban emergency department in Cincinnati, Ohio. The derivation sample included 92,635 patients; 504 (0.54%) were diagnosed with HIV infection. The validation sample included 22,983 patients; 168 (0.73%) were diagnosed with HIV infection. The final score included age, gender, race/ethnicity, sex with a male, vaginal intercourse, receptive anal intercourse, injection drug use, and past HIV testing, and values ranged from -14 to +81. For persons with scores of <20, 20-29, 30-39, 40-49, and ≥50, HIV prevalences were 0.31% (95% confidence interval (CI): 0.20, 0.45) (n = 27/8,782), 0.41% (95% CI: 0.29, 0.57) (n = 36/8,677), 0.99% (95% CI: 0.63, 1.47) (n = 24/2,431), 1.59% (95% CI: 1.02, 2.36) (n = 24/1,505), and 3.59% (95% CI: 2.73, 4.63) (n = 57/1,588), respectively. The risk score accurately categorizes patients into groups with increasing probabilities of HIV infection.
AB - Targeted screening remains an important approach to human immunodeficiency virus (HIV) testing. The authors aimed to derive and validate an instrument to accurately identify patients at risk for HIV infection, using patient data from a metropolitan sexually transmitted disease clinic in Denver, Colorado (1996-2008). With multivariable logistic regression, they developed a risk score from 48 candidate variables using newly identified HIV infection as the outcome. Validation was performed using an independent population from an urban emergency department in Cincinnati, Ohio. The derivation sample included 92,635 patients; 504 (0.54%) were diagnosed with HIV infection. The validation sample included 22,983 patients; 168 (0.73%) were diagnosed with HIV infection. The final score included age, gender, race/ethnicity, sex with a male, vaginal intercourse, receptive anal intercourse, injection drug use, and past HIV testing, and values ranged from -14 to +81. For persons with scores of <20, 20-29, 30-39, 40-49, and ≥50, HIV prevalences were 0.31% (95% confidence interval (CI): 0.20, 0.45) (n = 27/8,782), 0.41% (95% CI: 0.29, 0.57) (n = 36/8,677), 0.99% (95% CI: 0.63, 1.47) (n = 24/2,431), 1.59% (95% CI: 1.02, 2.36) (n = 24/1,505), and 3.59% (95% CI: 2.73, 4.63) (n = 57/1,588), respectively. The risk score accurately categorizes patients into groups with increasing probabilities of HIV infection.
KW - Decision support techniques
KW - HIV
KW - HIV infection
KW - Prediction
KW - Prevalence
KW - Validation
UR - http://www.scopus.com/inward/record.url?scp=84859717330&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84859717330&partnerID=8YFLogxK
U2 - 10.1093/aje/kwr389
DO - 10.1093/aje/kwr389
M3 - Article
C2 - 22431561
AN - SCOPUS:84859717330
SN - 0002-9262
VL - 175
SP - 838
EP - 846
JO - American journal of epidemiology
JF - American journal of epidemiology
IS - 8
ER -